Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Receivables (2016 - 2025)

INVO Fertility (IVF) has disclosed Receivables for 15 consecutive years, with $274200.0 as the latest value for Q3 2025.

  • On a quarterly basis, Receivables rose 6.67% to $274200.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $274200.0, a 6.67% increase, with the full-year FY2024 number at $174881.0, up 24.43% from a year prior.
  • Receivables was $274200.0 for Q3 2025 at INVO Fertility, up from $242255.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $807811.0 in Q1 2021 to a low of $47869.0 in Q2 2021.
  • A 5-year average of $168870.1 and a median of $116781.0 in 2023 define the central range for Receivables.
  • Peak YoY movement for Receivables: surged 21738.63% in 2021, then plummeted 92.73% in 2022.
  • INVO Fertility's Receivables stood at $50470.0 in 2021, then soared by 52.86% to $77149.0 in 2022, then surged by 82.18% to $140550.0 in 2023, then grew by 24.43% to $174881.0 in 2024, then soared by 56.79% to $274200.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Receivables are $274200.0 (Q3 2025), $242255.0 (Q2 2025), and $173614.0 (Q1 2025).